AtaiBeckley (ATAI) Interest & Investment Income (2020 - 2026)
AtaiBeckley (ATAI) posted quarterly Interest & Investment Income of $78000.0 for Q1 2026, down 58.06% year-over-year from $186000.0 in Q1 2025, and down 58.06% quarter-over-quarter from $186000.0 in Q1 2025.
Powered by 
Analysis
AtaiBeckley (ATAI) Interest & Investment Income (2020 - 2026) Analysis & Trends
AtaiBeckley has reported Interest & Investment Income for 6 years, with the latest figure at $504000.0 in Q3 2025.
- Quarterly Interest & Investment Income rose 215.0% year-over-year to $504000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $1.1 million (down 8.86% YoY) and the FY2024 annual result came in at $778000.0, down 57.88% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $78000.0, down from $186000.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $186000.0 in Q1 2025, with the low at $78000.0 in Q1 2026.
- A 5-year average of $227052.6 and a median of $186000.0 in 2025 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2022 and 2024: Interest & Investment Income surged 1712.5% in 2022, then tumbled 73.86% in 2024.
- Over 5 years, Interest & Investment Income stood at $125000.0 in 2021, then jumped by 49.6% to $187000.0 in 2022, then soared by 250.8% to $656000.0 in 2023, then slumped by 70.58% to $193000.0 in 2024, then jumped by 161.14% to $504000.0 in 2025.
- According to Business Quant data, Interest & Investment Income over the past three periods registered $504000.0, $248000.0, and $186000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.26 Bn | 131.41 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.64 Bn | 77.64 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 57.83 Bn | 52.69 Bn | 52.00 Mn | 67.00 Mn |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | 35.58 Mn |
| 6 | BeOne Medicines | 39.94 Bn | 34.84 Bn | 1.53 Bn | 27.90 Mn |
| 7 | Alnylam Pharmaceuticals | 35.19 Bn | 31.88 Bn | 992.69 Mn | 28.14 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | 5.13 Mn |
| 9 | Insmed | 27.35 Bn | 26.19 Bn | 358.27 Mn | 10.98 Mn |
| 10 | AtaiBeckley | 1.60 Bn | 1.60 Bn | - | 504,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 79,000.00 |
| Mar 31, 2026 | 78,000.00 |
| Sep 30, 2025 | 504,000.00 |
| Jun 30, 2025 | 248,000.00 |
| Jun 30, 2025 | 248,000.00 |
| Mar 31, 2025 | 186,000.00 |
| Mar 31, 2025 | 186,000.00 |
| Dec 31, 2024 | 193,000.00 |
| Sep 30, 2024 | 160,000.00 |
| Jun 30, 2024 | 118,000.00 |
| Mar 31, 2024 | 307,000.00 |
| Dec 31, 2023 | 656,000.00 |
| Sep 30, 2023 | 612,000.00 |
| Jun 30, 2023 | 303,000.00 |
| Mar 31, 2023 | 275,000.00 |
| Dec 31, 2022 | 187,000.00 |
| Sep 30, 2022 | 145,000.00 |
| Jun 30, 2022 | 117,000.00 |
| Mar 31, 2022 | 98,000.00 |
| Dec 31, 2021 | 125,000.00 |